Clinical correlation analysis revealed that elevated EPS8L2 expression is associated with advanced tumor grade, lymph node metastasis, and unfavorable patient prognosis, suggesting its potential role in CRC progression and aggressiveness. This evidence concerns the gene EPS8L2 and metastatic malignant neoplasm in the lymph nodes.